We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management.
- Authors
Ma, Cheng-Xu; Ma, Xiao-Ni; Guan, Cong-Hui; Li, Ying-Dong; Mauricio, Dídac; Fu, Song-Bo
- Abstract
Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2 diabetes mellitus (T2DM), particularly in low- and middle-income countries. To effectively prevent the development of CVDs in T2DM, considerable effort has been made to explore novel preventive approaches, individualized glycemic control and cardiovascular risk management (strict blood pressure and lipid control), together with recently developed glucose-lowering agents and lipid-lowering drugs. This review mainly addresses the important issues affecting the choice of antidiabetic agents and lipid, blood pressure and antiplatelet treatments considering the cardiovascular status of the patient. Finally, we also discuss the changes in therapy principles underlying CVDs in T2DM.
- Subjects
TYPE 2 diabetes; CARDIOVASCULAR diseases; GLYCEMIC control; BLOOD pressure; BLOOD lipids
- Publication
Cardiovascular Diabetology, 2022, Vol 21, Issue 1, p1
- ISSN
1475-2840
- Publication type
Article
- DOI
10.1186/s12933-022-01516-6